The largest network service provider in Romania, DIGI deploys OcNOS® products for OLT aggregation
SANTA CLARA, Calif., January 22, 2025 – IP Infusion, a global leader in open networking solutions, has been a key partner in DIGI Group's transition to a disaggregated networking strategy. DIGI, Romania's largest telecommunications provider, has successfully implemented IP Infusion's OcNOS Data Center and Service Provider software across its OLT aggregation infrastructure, supporting the company's extensive international growth over the past years.
DIGI has deployed IP Infusion software on several different hardware platforms, including products by UfiSpace 및 Edgecore. 화이트박스 하드웨어 호환성은 견고한 품질과 함께 낮은 비용 구조를 확보하면서, 업그레이드 가용성과 다양성을 보장합니다. 공통 네트워크 운영체제를 통해 각 거점이 서로 다른 기능을 요구하는 환경에서도 자산 보유와 운영 관리가 한결 수월해집니다.
"IP Infusion has delivered great results in terms of cost optimization, operational flexibility, and multi-vendor support," said Valentin Popoviciu, Executive Director of Digi Communications. "DIGI operates in Romania, Spain, Italy, Portugal and Belgium, providing state-of-the-art services to millions of customers. Our rapid expansion is underpinned by advanced, scalable and reliable networking solutions capable of adapting to the specific needs of each market."
"Servicing and complementing fast-growth organizations is a primary reason for our stellar market reputation," said Atsushi Ogata, President and CEO of IP Infusion. "OcNOS continues to demonstrate that open networking is the optimum networking platform of the future."
IP Infusion 소개
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
About DIGI Group
DIGI is the telecommunications market leader in Romania for pay-TV distribution services, broadband internet and fixed-line telephony and the second mobile network operator as customers, ensuring the largest national fiber and mobile coverage. The company operates in Romania, Spain, Italy, Portugal and Belgium.
The connectivity and convergent electronic communication solutions rely on modern fiber optic networks and state-of-the-art technologies are the result of more than 30 years of intense growth and the reflection of DIGI know-how in building and operating them directly. DIGI also offers to its customers a diversified range of radio and TV content, such as: sports, news, movies, documentaries, music, and the Digi Online content service.
Media Contacts:
For IP Infusion
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
For DIGI Group
Raluca Popoviciu
Communication & CSR Department
comunicare@digi.ro
www.DIGI.ro
https://www.facebook.com/digipunctro
IP Infusion 소개
IP Infusion은 오픈 네트워킹 소프트웨어의 선도적 공급업체로, 서비스 사업자, 데이터센터, AI 패브릭 네트워크를 위한 통신사업자급 네트워크 운영체제 OcNOS를 제공합니다. 1999년부터 쌓아 온 네트워킹 전문성과 전 세계 600개 이상의 사업자를 바탕으로, IP Infusion은 Edgecore Networks, UfiSpace, Celestica 등 파트너의 검증된 개방형 하드웨어에서 개방적이고 멀티벤더이며 비용 효율적이고 유연한 네트워크 인프라를 구현합니다. IP Infusion은 ACCESS CO., LTD.(도쿄증권거래소: 4813)의 전액 출자 자회사입니다.
미디어 문의
For press inquiries, analyst briefings, or media materials, please 팀에 문의 or email pr@ipinfusion.com.
미래예측 진술
본 보도자료에는 IP Infusion의 제품, 기술 및 계획에 관한 미래예측 진술이 포함될 수 있습니다. 미래예측 진술은 공개일 현재 이용 가능한 정보에 기초하며 위험과 불확실성을 수반합니다. 실제 결과는 다를 수 있습니다. 제품 계획, 기능, 출시 시기 및 제공 여부는 예고 없이 변경될 수 있으며 약정, 약속 또는 법적 의무를 구성하지 않습니다. IP Infusion은 미래예측 진술을 갱신할 의무를 지지 않습니다.